Provided by Tiger Trade Technology Pte. Ltd.

Pacira Pharmaceuticals

24.67
+0.84003.52%
Post-market: 24.18-0.4900-1.99%18:29 EDT
Volume:475.37K
Turnover:11.61M
Market Cap:983.39M
PE:70.13
High:24.72
Open:23.91
Low:23.66
Close:23.83
52wk High:27.66
52wk Low:18.80
Shares:39.86M
Float Shares:36.37M
Volume Ratio:0.96
T/O Rate:1.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3518
EPS(LYR):0.1578
ROE:2.05%
ROA:1.48%
PB:1.46
PE(LYR):156.30

Loading ...

Pacira urges vote for board slate as DOMA seeks to replace three director nominees ahead of June 9 meeting

Reuters
·
May 28

Pacira Biosciences Inc - Urges Stockholders to Vote "for" Election of Pacira's Nominees on Blue Proxy Card

THOMSON REUTERS
·
May 28

Press Release: Pacira BioSciences Mails Letter to Stockholders Reiterating Confidence in the Company's Strategic Direction and Highly Qualified Nominees

Dow Jones
·
May 28

Pacira study shows Exparel reduces opioid use and costs

TIPRANKS
·
May 27

Pacira BioSciences Says Exparel Linked to Lower Opioid Use, Healthcare Costs

MT Newswires Live
·
May 27

Pacira says real-world study links EXPAREL to lower opioid use after outpatient shoulder replacement

Reuters
·
May 27

Pacira Biosciences Reports Real-World Study Showing Exparel® Use Was Associated With Reduced Opioid Use and Healthcare Costs in Patients Undergoing Total Shoulder Arthroplasty

THOMSON REUTERS
·
May 27

Pacira issues statement on DOMA’s ‘misleading’ statements

TIPRANKS
·
May 26

Pacira rebuts DOMA claims on EXPAREL intellectual property strategy

Reuters
·
May 26

Pacira urges vote for board nominees, rebuts activist DOMA criticism of Exp​​arel IP strategy

Reuters
·
May 26

BRIEF-Doma Perpetual Urges Pacira Biosciences Shareholders To Judge Sale Price Adequacy

Reuters
·
May 22

Doma Perpetual - Shareholders Should Decide IF Sale Price the Co Finds Through Disciplined, Board‑Supervised Process Is Adequate & in Best Interests

THOMSON REUTERS
·
May 22

Pacira activist DOMA urges vote for its nominees, presses strategic alternatives ahead of June 9 meeting

Reuters
·
May 22

Pacira Biosciences posts investor presentation ahead of annual meeting

Reuters
·
May 20

Pacira urges vote for its directors as activist DOMA seeks CEO ouster, company sale

Reuters
·
May 20

Barclays Sticks to Its Hold Rating for Pacira Pharmaceuticals (PCRX)

TIPRANKS
·
May 14

Doma Perpetual Capital Management Calls For Removal Of Pacira CEO And Strategic Sale

Reuters
·
May 13

Doma Perpetual: Nominates Eric De Armas, Christopher Dennis, and Oliver Benton Curtis Iii to Pacira Board

THOMSON REUTERS
·
May 13

Doma Perpetual: Owns About 7.5% of Pacira Biosciences

THOMSON REUTERS
·
May 13

Doma Perpetual Capital Management: Calls for Removal of Pacira CEO and Strategic Sale

THOMSON REUTERS
·
May 13